Librium (Chlordiazepoxide Hydrochloride)

Chlordiazepoxide binds to the benzodiazepine site on the GABA‑A receptor complex, acting as a positive allosteric modulator. This increases the frequency of chloride channel opening when GABA binds, enhancing inhibitory neurotransmission and producing calming, sedative, and anticonvulsant effects.

The appropriate dose of Librium is determined by the prescribing clinician based on the individual’s condition, age, liver function, and response to therapy. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety data for chlordiazepoxide in pregnancy and lactation are limited. Healthcare professionals generally recommend avoiding use unless the potential benefit outweighs the risk. Women who are pregnant, planning pregnancy, or breastfeeding should discuss alternatives with their doctor.

To request Librium, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will verify trade or institutional credentials before providing pricing, availability, shipping details and any necessary import documentation.

Librium (chlordiazepoxide) has a relatively long onset of action and a moderate half‑life compared with agents such as diazepam or lorazepam. It is often chosen for alcohol‑withdrawal management because of its smoother tapering profile, whereas other benzodiazepines may be preferred for rapid anxiolysis or short‑term sedation.

Librium should be stored at ambient temperature, preferably below 25 °C, in its original packaging to protect it from moisture and excessive heat. Keep the product out of reach of children and do not use if the packaging is damaged.

Librium is taken orally, usually as a tablet, with or without food as directed by a healthcare professional. The exact administration schedule—such as frequency and duration—will be individualized by the prescriber.

The most serious risks include respiratory depression, especially when combined with other CNS depressants, severe hypotension, paradoxical agitation, suicidal thoughts, and rare but severe allergic reactions such as Stevens‑Johnson syndrome. Immediate medical attention is required if any of these occur.

Librium is contraindicated in individuals with known hypersensitivity to chlordiazepoxide or other benzodiazepines, those with acute narrow‑angle glaucoma, and patients who are currently intoxicated with alcohol or other CNS depressants. Caution is also advised for patients with severe respiratory insufficiency or severe hepatic impairment.